摘要
目的观察和探讨卡马西平联合多虑平治疗原发性三叉神经痛的临床疗效。方法选取我院2009年至2011年的原发性三叉神经痛患者86例,将患者随机的分为治疗组和对照组各43例,治疗组使用卡马西平联合多虑平治疗,对照组使用卡马西平治疗,比较两组临床症状的改变状况。结果治疗组有效40例,总有效率93.0%,对照组有效35例,总有效率81.3%,差异均有统计学意义(P<0.05)。而且治疗组的不良反应少。结论卡马西平联合多虑平治疗原发性三叉神经痛的临床疗效好、安全性高,值得临床推广使用。
Objective Watch and discuss carbamazepine joint doxpin treatment of the clinical curative effect of trigeminal neuralgia. Methods Select from year 2009 to 2011 in 86 cases of primary trigeminal neuralgia, will the patients were randomly divided into the treatment group and control group, the 43 cases, treatment used carbamazepine joint doxpin treatment, and the control group use carbamazepine treatment, compared with two groups of clinical symptoms change status. Results 40 cases, effective treatment group total effectiveness 93.0%, effective 35 patients in the control group, the total effective rate 81.3%, were statistically significant difference （P〈0.05）. And the side effects of the treatment group less. Conclusions Carbamazepine joint doxpin treatment of trigeminal neuralgia of the clinical effect of good, high security, and promote the use of clinical.
出处
《中国医药指南》
2011年第35期36-37,共2页
Guide of China Medicine
